Success Metrics

Clinical Success Rate
99.0%

Based on 100 completed trials

Completion Rate
99%(100/101)
Active Trials
4(3%)
Results Posted
42%(42 trials)
Terminated
1(1%)

Phase Distribution

Ph phase_4
56
43%
Ph not_applicable
45
34%
Ph early_phase_1
2
2%
Ph phase_2
7
5%
Ph phase_3
12
9%

Phase Distribution

2

Early Stage

7

Mid Stage

68

Late Stage

Phase Distribution122 total trials
Early Phase 1First-in-human
2(1.6%)
Phase 2Efficacy & side effects
7(5.7%)
Phase 3Large-scale testing
12(9.8%)
Phase 4Post-market surveillance
56(45.9%)
N/ANon-phased studies
45(36.9%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

95.2%

100 of 105 finished

Non-Completion Rate

4.8%

5 ended early

Currently Active

4

trials recruiting

Total Trials

131

all time

Status Distribution
Active(7)
Completed(100)
Terminated(5)
Other(19)

Detailed Status

Completed100
unknown19
Recruiting4
Withdrawn4
Not yet recruiting3
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
131
Active
4
Success Rate
99.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (1.6%)
Phase 27 (5.7%)
Phase 312 (9.8%)
Phase 456 (45.9%)
N/A45 (36.9%)

Trials by Status

not_yet_recruiting32%
recruiting43%
withdrawn43%
terminated11%
unknown1915%
completed10076%

Recent Activity

Clinical Trials (131)

Showing 20 of 131 trialsScroll for more
NCT07835295Phase 4

REMIfentanil (2 vs. 4 mcg/kg) Facilitated Intubation Without Neuromuscular Blockade Versus Succinylcholine and Rocuronium With Sugammadex for Endotracheal Intubation in Spine Surgery Requiring Motor Evoked Potential Monitoring

Not Yet Recruiting
NCT07746726Phase 3

Safety and Efficacy of HRS-9190 Compared to Rocuronium for Tracheal Intubation and Bolus Maintenance in Adults

Recruiting
NCT06564857Phase 4

Remifentanil Versus Rocuronium for Optimizing Video Laryngoscopy-assisted Tracheal Intubation

Recruiting
NCT07730918Not Applicable

Low-dose Propofol Plus High-dose Alfentanil in Rapid Sequence Induction

Completed
NCT07627750Not Applicable

Low-Dose Rocuronium Maintenance During Spine Surgery With Intraoperative Neurophysiological Monitoring

Not Yet Recruiting
NCT07404579Phase 2

Safety and Efficacy of HRS-9190 Compared to Rocuronium for Bolus Maintenance in Adults

Completed
NCT05887375Phase 4

Sugammadex vs Neostigmine/Glycopyrrolate on Urinary Retention After Spine Surgery

Completed
NCT07464288Not Applicable

Effect of Neuromuscular Block Depth on Driving Pressure and Postoperative Respiratory Events in Abdominal Surgeries

Not Yet Recruiting
NCT07203287Phase 4

Risk of Acute Complications With Rocuronium vs Cisatracurium in Patients With Chronic Kidney Disease

Recruiting
NCT04760912Phase 4

General Anesthesia With and Without Muscle Relaxation and Muscle Strength Recovery

Completed
NCT05279898Not Applicable

Perioperative Multimodal General AnesTHesia Focusing on Specific CNS Targets in Patients Undergoing carDiac surgERies

Completed
NCT06225466Phase 4

Muscle Relaxation for Pediatric Adenotonsillectomy

Completed
NCT07064408Not Applicable

Subanesthetic Esketamine for Hemodynamic Stability and Recovery in Elderly Thoracic Surgery Patients

Completed
NCT04821817Not Applicable

Peribulbar Rocuronium in Adult Strabismus Surgery

Completed
NCT06707532Not Applicable

The Potential Protective Effect of Using Muscle Relaxants During Electroporation Ablation (PFA)

Recruiting
NCT05596227Not Applicable

Ultrasound Guided Erector Spinae Block vs Thoracolumbar Interfascial Plane Block

Completed
NCT05909696Not Applicable

Median Effective Dose of Rocuronium for the Prevention of Myofibrillation Caused by the Injection of Succinylcholine

Completed
NCT02631135Phase 4

Cognitive Functions After TIVA With Dexmedetomidine

Completed
NCT04868409Phase 4

Intubating Conditions During Rapid Sequence Induction in Elderly With Either Suxamethonium 1.0 mg/kg or Rocuronium 1.0 mg/kg

Completed
NCT03939923Phase 4

Role of Sugammadex as Reversal Agent in Patients Extubated Immediately After Isolated Coronary Artery Bypass Grafting Surgery

Completed

Drug Details

Intervention Type
DRUG
Total Trials
131